The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Understanding male breast cancer in the community setting.
A. L. Ginsburg
No relevant relationships to disclose
D. A. Patt
Employment or Leadership Position - US Oncology
J. Flinn
No relevant relationships to disclose
J. L. Espirito
No relevant relationships to disclose
M. A. Neubauer
Employment or Leadership Position - US Oncology
T. H. Cartwright
Employment or Leadership Position - US Oncology
Consultant or Advisory Role - Amgen; Genentech; Lilly; Sanofi
Honoraria - Amgen; Lilly; Roche; Sanofi
J. R. Hoverman
Employment or Leadership Position - US Oncology
L. T. Busby
No relevant relationships to disclose
B. D. Brooks
Employment or Leadership Position - US Oncology
Consultant or Advisory Role - Amgen
Honoraria - Eisai
M. A. Kolodziej
Employment or Leadership Position - US Oncology
M. A. Sitarik
Employment or Leadership Position - US Oncology
Consultant or Advisory Role - Eisai; Eisai; Pfizer (U)
R. W. Anderson
No relevant relationships to disclose
R. A. Beveridge
Employment or Leadership Position - US Oncology; US Oncology
Honoraria - US Oncology
Research Funding - US Oncology